Myocardial Infarction
Showing NaN - NaN of 27
Myocardial Infarction Trial in Worldwide (Tenecteplase, Clopidogrel, Coronary angiography)
Active, not recruiting
- Myocardial Infarction
- Tenecteplase
- +3 more
-
Liverpool, Australia
- +49 more
Dec 20, 2022
Myocardial Infarction Trial in Worldwide (Empagliflozin, Placebo)
Recruiting
- Myocardial Infarction
- Empagliflozin
- Placebo
-
Alexander City, Alabama
- +464 more
Aug 22, 2022
Heart Attack Research Program- Imaging Study
Recruiting
- Myocardial Infarction
- OCT
- CMR
-
Birmingham, Alabama
- +18 more
Jul 18, 2022
Carotid Intraplaque Neovascularization Combined With Stress Echo
Recruiting
- Atherosclerosis
- +5 more
- Carotid Contrast Enhanced Ultrasound
-
Calgary, Alberta, Canada
- +3 more
Jun 8, 2022
Myocardial Infarction, Anemia Trial in Worldwide (Red Blood Cell Transfusion)
Recruiting
- Myocardial Infarction
- Anemia
- Red Blood Cell Transfusion
-
Little Rock, Arkansas
- +131 more
May 3, 2022
Heart Failure, Myocardial Infarction Trial in Canada, Puerto Rico, United States (High Dose Trivalent Influenza Vaccine,
Completed
- Heart Failure
- Myocardial Infarction
- High Dose Trivalent Influenza Vaccine
- Standard Dose Quadrivalent Influenza Vaccine
-
Birmingham, Alabama
- +189 more
Dec 22, 2021
Myocardial Infarction Trial in Edmonton, Saskatoon (Early Access CR)
Suspended
- Myocardial Infarction
- Early Access CR
-
Edmonton, Alberta, Canada
- +1 more
Nov 4, 2021
Intraoperative Hyperoxia and MINS
Unknown status
- Hyperoxia
- +2 more
- Inspiratory oxygen fraction
-
Cleveland, Ohio
- +7 more
Feb 3, 2021
Myocardial Infarction Trial in Worldwide (Eplerenone, Placebo)
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Myocardial Infarction Trial in Worldwide (primary PCI, enoxaparin, catheterisation)
Completed
- Myocardial Infarction
- primary PCI
- +4 more
-
Salzburg, Austria
- +200 more
Jun 6, 2019
Myocardial Infarction Trial in Edmonton (MedBIKE)
Completed
- Myocardial Infarction
- MedBIKE
-
Edmonton, Alberta, CanadaJim Pattison Centre for Heart Health, Mazankowski Heart Institut
Oct 11, 2018
Myocardial Infarction Trial in Canada (tenecteplase, enoxaparin, clopidogrel)
Completed
- Myocardial Infarction
- tenecteplase
- +3 more
-
Edmonton, Alberta, Canada
- +15 more
May 18, 2017
Myocardial Infarction Trial in Worldwide (Percutaneous Coronary Intervention (PCI), RO4905417, )
Completed
- Myocardial Infarction
- Percutaneous Coronary Intervention (PCI)
- +2 more
-
Huntsville, Alabama
- +65 more
Nov 1, 2016
Myocardial Infarction, Sudden Death Trial in Worldwide (Implantable Cardioverter Defibrillator + Usual Care, Usual care)
Unknown status
- Myocardial Infarction
- Sudden Death
- Implantable Cardioverter Defibrillator + Usual Care
- Usual care
-
Huntsville, Alabama
- +93 more
Jul 7, 2016
Cardiovascular Diseases, Heart Diseases, Cerebrovascular Accident Trial in Canada, United States (Extended release niacin,
Terminated
- Cardiovascular Diseases
- +5 more
- Extended release niacin
- Simvastatin
-
Birmingham, Alabama
- +90 more
Mar 8, 2016
Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor
Completed
- Myocardial Infarction
- +3 more
- Ticagrelor 90 mg
- +2 more
-
Alexander City, Alabama
- +846 more
Dec 18, 2015
Acute Coronary Syndrome, Myocardial Infarction, Smoking Trial in Worldwide (Bupropion HCl ER, Placebo)
Completed
- Acute Coronary Syndrome
- +2 more
- Bupropion HCl ER
- Placebo
-
Pueblo, Colorado
- +37 more
Apr 10, 2015
Acute Coronary Syndrome, Myocardial Infarction, Myocardial Ischemia Trial in Worldwide (Rivaroxaban 2.5 mg, Rivaroxaban 5 mg,
Completed
- Acute Coronary Syndrome
- +3 more
- Rivaroxaban 2.5 mg
- +3 more
-
Birmingham, Alabama
- +583 more
Aug 26, 2014
Myocardial Infarction Trial in Worldwide (abciximab ; reteplase , abciximab, abciximab, Abciximab; reteplase; abciximab ;
Completed
- Myocardial Infarction
- abciximab placebo; reteplase placebo, abciximab, abciximab
- +2 more
-
Phoenix, Arizona
- +234 more
Jul 25, 2014
Myocardial Infarction, Stroke, Renal Failure Trial in Edmonton (atorvastatin 80 mg per os daily, )
Completed
- Myocardial Infarction
- +2 more
- atorvastatin 80 mg per os daily
- placebo
-
Edmonton, Alberta, CanadaUniversity of Alberta
Dec 15, 2011
Myocardial Infarction, Heart Failure, Heart Enlargement Trial in Canada, Poland, United States (PG-116800 (given as PG-530742),
Completed
- Myocardial Infarction
- +2 more
- PG-116800 (given as PG-530742)
- Placebo tablet
-
Little Rock, Arkansas
- +51 more
Sep 27, 2011
Myocardial Infarction Trial in Canada, United States (, PRT060128 Potassium)
Terminated
- Myocardial Infarction
- placebo
- PRT060128 Potassium
-
Tallahassee, Florida
- +30 more
Dec 28, 2010